For many biopharmas, it takes years of hard work to transition from being a clinical-stage drugmaker to a commercial one.

Every year, Fierce’s pharma, biotech, and medtech teams come together to spotlight some of the fiercest women in life s | ...

For Big Pharma, recent headlines out of China suggest multinational drugmakers are facing their share of challenges in the ...

While president-elect Donald Trump has already made his leadership picks for the Department of Health and Human Services (HHS ...

As a council of outside experts prepares to meet Thursday to discuss AstraZeneca’s Andexxa, the FDA has flagged “major safety ...